Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 mai 2018 19h34 HE | Source: Invivoscribe, Inc.

Invivoscribe presenta la solicitud de aprobación previa a su comercialización en Japón y un Panel Track Supplement en EE. UU. para detectar pacientes con leucemia mieloide aguda (AML) por mutaciones de FLT3

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies, Inc. anunció hoy que se han presentado ante la Agencia de Dispositivos Farmacéuticos y Médicos de Japón (PMDA) y ante los...
08 mai 2018 19h34 HE | Source: Invivoscribe, Inc.

Invivoscribe envia candidatura para aprovação antes da comercialização no Japão e suplemento painel de rastreio nos EUA para examinar pacientes com leucemia mieloide aguda (LMA) quanto a mutações FLT3

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- A Invivoscribe Technologies, Inc. anunciou hoje que enviou à Agência de Dispositivos Farmacêuticos e Médicos (PMDA, em inglês) do Japão e à Administração...
08 mai 2018 19h34 HE | Source: Invivoscribe, Inc.

Invivoscribe Menghantar Permohonan Kelulusan Pra Pasaran di Jepun dan Trek Panel Tambahan di AS untuk Saringan Pesakit Leukemia Mieloid Akut (LMA) untuk Mutasi FLT3

SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies, Inc. hari ini mengumumkan bahawa mereka telah menghantar pendaftaran produk kepada Agensi Farmaseutikal dan Peranti Perubatan...
08 mai 2018 19h34 HE | Source: Invivoscribe, Inc.

インビボスクライブ、急性骨髄性白血病 (aml) 患者のflt3変異スクリーニングについて、日本における製造販売承認申請と米国におけるパネル追跡補足を提出

サンディエゴ発 , May 09, 2018 (GLOBE NEWSWIRE) -- インビボスクライブ･テクノロジーズ (Invivoscribe Technologies, Inc.) は本日、成人患者におけるFLT3変異陽性 (FLT3mut+) の再発性または難治性急性骨髄性白血病 (AML) の治療のためにギルテチニブを評価している第III相CL-0301アドミラル...
08 mai 2018 19h34 HE | Source: Invivoscribe, Inc.

Invivoscribe为急性骨髓性白血病患者FLT3基因突变筛查技术在日递交上市前审批申请和在美递交申请补充材料

圣地亚哥, May 09, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies, Inc.今日宣布，已为目前处于III期临床阶段的CL-0301...
08 mai 2018 19h34 HE | Source: Invivoscribe, Inc.

Invivoscribe分別在日本和美國遞交上市前審核申請和小組追蹤補充資料，以便對急性骨髓性白血病（AML）患者進行FLT3突變篩檢

聖地牙哥, May 09, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies, Inc.今天宣佈，該公司已根據持續進行的第III期CL-0301...
08 mai 2018 06h00 HE | Source: Invivoscribe, Inc.

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies, Inc. announced today that they have submitted to Japan’s Pharmaceutical and Medical Devices Agency (PMDA) and the US Food and...
25 août 2017 08h50 HE | Source: Dynamic Solutions Worldwide, LLC

Dynamic Solutions Worldwide Named to Inc. Magazine’s List of America’s Fastest Growing Companies, Inc. 5000

MILWAUKEE, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Dynamic Solutions Worldwide, LLC is the creator of DynaTrap® (www.dynatrap.com), a technology-driven, indoor/outdoor insect and mosquito traps that are...
18 août 2017 17h00 HE | Source: Carahsoft Technology Corporation

Carahsoft Listed on the Inc. 5000 List for the Tenth Consecutive Year

RESTON, Va., Aug. 18, 2017 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp., the trusted government IT solutions provider, today announced that it has been ranked #3255 by Inc. magazine today on its...
17 août 2017 07h38 HE | Source: DAS Health

For 6th Year DAS Health Listed on Inc. 5000 Fastest Growing Companies

Tampa, Aug. 17, 2017 (GLOBE NEWSWIRE) -- For an impressive sixth year in a row, DAS Health has been named among the Inc. 500|5000 fastest-growing private companies in America. A Tampa-based health...

Page précédente

Page suivante